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Dr. Mann (1) has aptly described the liver as the "commissariat of 
the body". Being the largest gland in the body, the liver engages in a multi-
plicity of known functions and a probable host of unknown functions. Its des-
cribed functions include hematopoietic processes, detoxification, reticulo-
endothelial tunctions, water balance, and the all important metabolism of food 
material to provide rapid utilizable energy for the tissues. The complexity 
and fluctuation of function must be emp~sized in order to evaluate the accu-
mulating mass of data concerning hepatic· function. ~l the activities of this 
organ are not affected to the saae degree by a disease process. The functional 
status of the liver is dependent on the physiological or pathological status of 
a number of other organs. Damage up to ~ighty percent (2) does not cause ab-
normal results in liver function tests perfo~ed upon experimental animals. 
Closely allied to the large reserve power is the remarkable regenerative power 
of the gland which may completely mask the pathological lesion. Diet, impaired 
renal function, or faulty intestinal absorption may also affect the results ob-
tained in the various liver function tests. Hoffbauer and his co-workers (3) 
have recently pointed out the value of a composite study of liver functions. 
Several investigators (3,4,5,6,7,8) have made use of the liver biopsy in an at-
tempt to correlate morphological change with impaired liver functions. 
This paper presents a series of liver tunotion tests made in oonjuno-
tion with a micro-chemical and microscopic examination of material obtained by 
liver biopsy. The tunction teats selected were based upon the secretory and ex-
cretory tnnctions of the liver, the detoxification process, and the roles played 
by carbohydrate, protein, and lipid metabolism in the diseased liver. The bi-
opsies proved advantageous in studying the dynamios of the diseased liver when 
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proper precautions were used. The precautions observed were: 
a - contamination ot the specimen. with blood was reduced to a minimum; 
b - tissue tor chemical analysis was placed immediately in potassium hydroKide 
solution and tissue weight deta~1ned; 
c - specimens tor pathological examination were placed in saline packs and sent 
to the laboratory tor examination directly atter the operations. Another 
advantage ot tissue analysis lay in the tact that samples could be obtained 
and studied at trequent intervals during lite. 
The hazards ot random sampling were taken into account in evaluating 
the re8ults. The biopsies were alwaY8 performed at the same hour ot the day, 
on patients in a tasting 8tate, in order to avoid the diurnal variations ot 
11 Ter glycogen (43). Gomori and Goldner (44) advocate great caution in judging 
the metabolic state ot the liver on the basis ot the glycogen content ot biopsies. 
They observed Variations exceeding several hundred percent in samples taken trom 
the same i.o:be ot a rabbit t s 11 ver. While cauti on should be used in judging the 
biopsy tindings, variations ot that degree are not expected in man (45); the 
rabbit has one ot the greatest variations ot all experimental animals (46). 
Deane and his group (47) t using rats, ran a series ot micro-chemical liver gly-
cogen determinations and tound the ditterence in readings not to exceed tour per-
cent ot their _an. These investigators also showed histologically that atter six 
to twelve hours starvation (a period similar to that ot our patients), glycogen 
is still abundant and either distributed evenly or concentrated peripherally in 
the lobules. Our micro-chemical glycogen results were checked against the pa-
tholOgist's report. 
The data reported in this paper was obtained trom sixteen patients at 
LoUisville General Hospital; the clinical diagnosis on these patients was cirrhosis 
ot the liver. Cirrhosis, by our detinitign, is a chronic disease characterized by 
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degeneration of the liver parenchyma with fatty destruction and necrosis of 
the individual cells. There is fibrous tissue proliferation and subseQqent re-
generation of parenchymal cells resulting in a changed lobular and vascular 
pattern (9, 10). 
Methods 
1. Total Protein: 
This aabstance was determined on serum.bY a micro~jeldahl method employing 
direct nesslerization. An appropriate correction for non protein nitrogen was 
applied (11). The procedure was a modification of Wong (12) with peroxide re-
plaCing persulfate for the oxidation. A Universal Spectrophotometer was used 
to measure the density of the nesslerized solutions against an ammonium sulfate 
standard. 
2. Albumin and Globulin: 
The low temperature methanol precipitation of serum globulin as recommended 
by Pillemer and Hutchinson (13) was used. The results obtained by this method 
compare favorably with those obtained throagh electrophoretiC analyses. Sodium 
sulfate precipitation of globulins (Howe'S method) led to quantitative inaccuracies 
in determination of albumin and globulin according to Pillemer and Hutchinson (13). 
Our laboratory verified the reports of incomplete separation of albumin and globulin 
when Howe's salting out method was employed. 
3. Cephalin Cholesterol Flocculation Test: 
This test was performed as outlined in Kolmer and Boerner (23). The resu1ts 
were graded from 0 to 4 +. 
4. Thymol Turb~dity Test: 
The procedure described by Maclagen (24) was used. 
5. Colloidal Gold Test: 
Gray's method (25) was employed. 
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6. prothrombin: 
The method ot Quick as outlined in Kolmer and Boerner (27) was tollowed in 
determining prothrombin. 
7. Cholesterol - tree and total: 
The Schoenheimer-Bperry (21) procedure employing digitonin preCipitation was used. 
8. Lipase: 
Thi s enzyme was determined by the method ot Cherry and Crandall (26) who recom-
mended the use of an olive oil emulSion as the SUbstrate •• 
9. Bromsulphale1n test: 
Th1s test was pertormed according to the directions stated in KQlmer and Boerner 
(16). When 1 eo. ot dye per 10 kg. of body weight was injected intravenously, the 
test results were interpreted according to the t~llowing seale: 
10% or less dye retention at 30 minutes - no liver impairment 
20% - 40% dye retention - slight impairment 
50% - 80% dye retention - moderate impairment 
90% or greater dye retention - severe impairment 
10. Serum Bilirubin: 
The method ot Malloy and Evelyn. (19) was employed. 
11. Hippuric Acid Excretion Test: 
Quick's intravenous modification was used (17,18) in order to eliminate the 
tactor of faulty intestinal absorption. The intravenous injection contained 1.77 
gn. of sodium benzoate (equivalent to 1.5 gm. of benzoic acid) dissolved in 20 ml. 
ot distilled water. 
12. Non protein Nitrogen: 
The Haden modification of a Folin-Wu protein-tree filtrate (14) was used for the 
determination. An aliquot of this filtrate was used to determine the nitrogen 
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according to the method of Koch and McMeekin (15). 
13. ~lase (Diastase): 
This substance was deter.mined by the incubation of serum according to a mOdi-
fied Somogyi (31) procedure. The reduction power of the enzymatic degradation 
products'of the starch was determined using the glucose method described _.low. 
14. Glucose: 
Whole blood was deproteinized with zinc sulfate and sodium hydroxide (28). The 
new copper reagent developed by Somogyi ,{28) was used to detelmine the reducing ~ 
power of the glucose. Nelsonts areeBomolybdate solution (30) was employed as the 
chromogenic reagent. 
15. Galactose Tolerance Test: 
The intravenous test was performed according to the directions of Bassett and 
Althausen (32) Glucose was removed from the blood samples by fermentation with 
yeast (33) and the filtrates were then analyzed tor galactose. 
16. Glycogen: 
The biopsied liver,tissue was analyzed tor glycogen according to the method 
described by Wagtendonk, et al (34) with the following moditlcations: 
a - The precipitated glycogen was placed in a vacuum dessicator overnight to 
insure its complete dryness; 
b - The glycogen-iodine color complex was develop~d over a thirty minute period 
in a constant tamperature water bath (35). Preceedlng biopsy analyses the 
Wagtendonk method was tested with guinea pigs. Twelve liver samples trom 
these experimental animals were analyzed for glycogen content; 1 mg. ot 
glycogen was added to each ot twelve additional samples and adequate re-
covery was obtained. 
Since, in the Wagtendonk method, the tissue glycogen was compared against 
- 6 -
a standard glyco~n solution, the purity ot that solution had to be determined. 
The standard containe4 100 mg. ot glycogen (Eastman Kodak Co.) dissolved in 100 cc. 
ot 3:5% potassium hydroxide. The purity ot the glyeo~n was determined as tollows: 
Glycogen was precipitated trom 5 cc. ot the standard solution (100 mg. %) with 
10-15 cc. ot 9~ .thanol as the precipitating agent. This reaction was continued 
overnight in Pyrex testtubes. Addition ot a 1% aqueous solution ot sodium sultate 
(36) seemed unnecessary to insure c_plete precipitation. The tubes were centri-
tuged at high speed, the supernatant decanted, and the alcohol tumes expelled by 
heat or aspiration in a vacuum dessieator. The precipitated glycogen was subject 
to acid hydrolysis with ~7.5 cc. ot normal hydrochloric acid (2.2%) tor a two 
hour period in a boiUng water bath. Sahyun and lisberg (37) have determined 
that hydrolysis with normal h,drochlorie acid 1s completed in two hours. It is 
important to replace the liquid bOiled ott during hydrolysis in order to prevent 
charring. Sahyun (38) used tin toil to cover the mouth ot the test tube while 
Good, Kramer, and Somogyi (39) recommended an air co~ser. We found the addition 
of a tew drops ot water at thirty minute intervals prevented any signs ot charring. 
Sjogren and his group (40) have clearly demonst*&ted the eftect ot acid concentra-
tion on the hydrolYSiS ot glycogen as shown in the follOWing graphs: 
Mg. ot glycogen Kg of glycogen 
2.0 . 2.0 
1.5 




o 10 20 30 40 50 60 o 30 60 90 120 
Time in minutes Time 1n .minutes 
Fig. I - Hydrolysis of I1g. II - Hydrolysis ot glycogen 
glycogen with 5 N sulturic acid with 0.75N sulturic acid 
The acid hydrolysate was transfwrred to a 50 ml. volumetric flask with 
washing and neutralized with normal sodium hydroxide using phenolphthalein as the 
indicator. The sample was then made up to volume with distilled water. Aliquot 
portions (2 ml.) of this solution were tested for glucose content according to 
the Somogyi method previously mentioned. The results were calculated with the 
following formula: 
( densi ty x ) (mg. of glucose) (100 ) ( ) 
(----------------) ( in the ) (-----------) (0.927)-- mg.% glycogen. 
(densi ty standard) (standard ) (mg.: x used ) ( ) 
The purity was ascertained to be 98.l7~ and this figure was rechecked eight times. 
We retained the theoretical factor 0.927 for the conversion of glucose values to 
glycogen although Nerking (41) has questioned its validity. He argues, on the 
basis of experimental evidence. that the factor should approach 0.95. but no de-
finite conclusions have been reached. 
The classio principles laid down by Pfluger were tollowed in the tissue 
analyses - e.g. 
1 - destruction ot tissue by alkali, the glycogen remaining unaftected; 
2 - precipitation ot the glyoogen; 
3 - hydrolysis of the precipitated glycogen to glucose and subsequent determina-
tion of the amount ot glucose by a standard sugar technique. 
Aocording to the reports ot Saandinavian investi gators (42), the normal 
value tor glycogen trom excised 11 Ter tissue was tound to be 6-7%, They reported 
values ot 5.6~ glycogen upon analysis of liver tissue trom oirrhotic patients. 
A three day period was required to complete all the various liver 
function. tests and biochemical determinations on a Single patient. 




Globulin - - - -
A/G ratio - - - - -
Cephalin cholesterol tlocculation - -
Colloidal @Pld --
Thymol turbidity - - - - - - - -




Lipase - - - - - - -
Brom sulphalein dye •• cretion - - - -
Bilirubin - - - - - - - - -
Hippuric acid synthesis - - - - - - -
Nonprotein nitrogen - - - - - - -
Amylase - - - - - - - -
Glucose - - - - - -
Galactose tolerance test - - - -
Glycogen - - - - - - - - - - - - - -
Normal range 
6.5 - 8.5 f!JJ1% 
4 - 5 f!JJ1% 
1.5 - 2.5 f!JJ1% 
1.5 - 2.5 
o - 1+ 
curves not exceeding an initial value ot 4 
o - 4 units 
80 - 100% (clotting time 12-13 seconds) 
110 - 390 mg$ 
70 - 230 ~ 
60 - 70 % 
0.2 - 1.0 cc N/20 sodium hydroxide 
10% or less dye retention in 30 minute 
specimen 
0.1 - 0.5 mg% 
0.7 f!JJ1 sodium benzoate excreted in 1 hour 
20 - 40 mg% 
80 - 180 mg% 
70 - 100 mg% 
o - 30 mg% galactose in 75 minute specimen 
6 - 7 % 
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Discussion of Results 
A - Proteins: -
The liver is intimately concerned with the formation of the blood proteins 
although other tissues of the body appear to synthesize, particularly the globulin 
fraction. Therefore, 1n hepatic dys function changes in the quantity and the 
quality ot the proteins would be expected. Electrophoretic studies (48) confirm 
the fact that a striking increase in the gamma globulin fraction is one of the 
most consistent findings in cirrhosis. 'In conjunction with other investigators 
(49, 50, 51, 52) we find a striking and consistent reversal of the A/G ratio. 
The decreased production of albumin (the smallest molecular weight blood protein) 
results in an absolute increase of gamma, beta, and alpha globulins (larger molecular 
weight fractions). This reversal ot ratiO, when considered with other test results, 
is valuable in diagnosing the amount of parenchymal damage (53) in a hepatic disease 
process. However, alteration of the ratio within itself has no specific value, 
since such alterations can occur in the extra-hepatic damage. 
fbe total protein appears to stay within nora,al limits in cirrhosis. 
The slightly high value found in ease 4 might be explained on the basis of the 
great increase in serum globulin or dehydration. 
~- Specific tests for gamma globulin: 
This series of tests includes cephalin cholesterol flocculation, thymol turbidity, 
and colloidal gold which give positive reactions in the presence of increased serum 
gamma globulin. 
The cephalin cholesterol flocculation test was developed by Hanger in 
1938 (22, 70). ElectroPhoretic studies (72) proved that gamma globulin isolated 
from normal and pathological sera showed marked cephalin flocculation activity. 





















~ [,i ti ~ 
tt' .'=t: Itt I r-ti ;! i lt< i:t 
~ ITij t± ih,i 
H+ia. H+ t± II !=t IT: BfEf tt 
~I ~I r!: H I:t: !:f tl 11 U HR± Ie, 
:ft: ltu I~: :, d:: tf !g i ~ w ~ 
~~ 1:J:i:j: ttlll ~ ~ Ir ·tm 
'~ :00 'ijlmlH '7 l It ~ .,~ 
ttW $t'g#! ~ ~ I~~ ~: iImr7iJjlWIJlll ij :mlff [J ! ~ .~~, 
!:;: ~ In :± .~Ufj III 100 ffiJrfm J Ii :it" 8 :d; 1:1' 
3 
H ~ A liiI ltf I~m H·rt ~ til 
tt~~ It ~ n f! ~ tla ~ m t! :+ 
~ : rn IT if ~ ~ ~ 1 ~ ~ 
" It t I~ 1#;11$ lfi ~ j IE gl l ~ Ii" [f 
n, ±:. It '(:w r 1~+lt ;; : :~I~: ~;~ m:·,;.; IH IL -!f f ij ~ ~. ~ 
I If ~ ~i.' tt :: ,,-;-' :1!=W~ :: : ttrth I~[ 8 :m..; ,i l ,~~ \ ~Y'\ ; '! C";+; ,,1J.1 c;::;: rhFi+f . .. ., . :~;i ;;~ ;;: ~ tr ft 
+l H_LH-~_I+ 'H 1+11+, i!' l-f fH+ '11 !I clW J-IH +/"' 'I' ".' '/i, IF!, q Lj 
+ .. , t :j ~- m mr-.-fi:, J:H.,.i+l 
h"lli~ Ii .;:d ;t::t:t lili illi ,~11~ m :Q~~ I~It1I~ j: t:Ji lml 1m P=! ' k +I 1+1= :rm ci+t 
~:+I-i: It L IE bl :+:m! ~. ~mmlR W mI Hi HItllJmT;IImm -mm~lmlIE l 
tr' , ~it it ~8 ~:i! :lm trtfm lt 1 ill: .~ Wi l·it ~ :WIF 
~ 
:t :-i, T ~t ' : IJ: i: ' I~ ~ il I~ If Ii. " :~ ~! 
'I" t II { :g it!: :+ Ite> ilt If llii I~ .~ I~ § If: if Ii l!HiW:Ji J 
g+ Ig mn :il t ~t1 m if II..' Itf 1£5 ~:~ IE 1~lfJlit 
m~j;~ Hftttf:!' :ttl :r. If !~' Itt L :t :tfu If" ::tl ;; H 
:1 t:.; ::~ JHJt 
;: :* Eti l~: : [W~ DI+-' § :~ 
} ~' :: ~i 'i rtS?i Effl ','j !H~: II Eft: J Ilffi 
~~ tJ rr 
't ~ ! ~r:t .~ If tt;:~mt tml Ii·; I~ 
Ii::: ;'1 F! IW .. ' ; lill ~ll~m l:cf( It 1m rm l~"-' ' 
I~ tt-ti lili Ih U I '+++ I g:: ill In fHijrI ~ Ilmti mml! Ihf, 
, ~mlltfttt I:t Ll:!:t I:tt ltw :t; [1 TG; "'Jtt [b~fY Ur IH IE 1~1i r!l~IHP.lj f#+t ~ If Ip I" j-H I ' 
I l':ltlti It;. 'Wti 1t:+':tltW It tT Ir IHH~ 
I'-H I~ 1. ~ r 
1+;:11" "l:'~EWlmm L+: It ',r tM ff g ImimgliM mlrat g ~ ~[ I:'l~qffi ~ :It 1M T' . 
~'~ 1+ Ig :1 m it j:l It n lar1 ~jn lMlt lpi~lm ml+-~~n ~ [Hi If. iaulm 1m bliH H~ 
~ ~! 
.. ~ g ~+ If 1'1-: :~ I~ 'f j:t-:, IU lr 'l rn l!liJ l# lHl3 
It g ~ til n Itt oom a j ~ m IDffi ~ :! 1m rn ::: It 
.,. ~ It Ii 'l'l gfr' II It m ~ Fit ~ Imtlg 1m ~"ff ~ Im aI 1::1 
~ t If l!fg [g lUll ~ In :~ It :t ,I'" E§ 1m It' l:.i If $'+ ffi tm b I 
~ ~ t; IE f-, liff ~ I;ilm § I€f.:: ~JH~!~ ~r'1~ § (Him g IF 11fl !f Itt aff [gt111 Lt Mt at [till FE ~ ili=r h}f1OO g ~'.+ I j ''t' ~ 0 I\;~: 
I~ lmmm IEmIL • 1m IEmlli :ii tlID ,R ~h~~~ t~:~ [g g Igj!lml If H If;! IB Ittffi.tt rm Iff 1m 1m fHt !1m lti-:t Hg: 1$11 j :mw ~: I :. ,.I:+l:j , :+ l!ff ~: tfi', "" ttl m nm 
~ ,.A 4 l·ft . ~ ,II ,: 1 It . - , .1' I, " 
- 9 -
process in cirrhosis and was negative in those instances where residual scarring 
was apparently the sole lesion. Our results CO.lllpare favorably with tbose obtained 
by Hanger as may be seen from the- following table: 






f 3 ... 
e 
6 
2 + 1 + 0 
11 2 10 
13 5 3 
The test is simple to perform and reliable results can be obtained. The test is 
an index of active parenchymal damage rather than a measure of residual function (91). 
Gray (73) described the colloidal gold test in 1940. The test depends 
upon a qualitative change in the gamma globulin traction and addition of electro-
pnoretically separated albumin inhibits the reaction. In accordance with Gray we 
found the test remarkably sensitive yielding positive results in every case. How-
ever the technical details associated with preparation. standardization, and acidi-
fication of the gold solution render the test a difficult one to perfor.m. 
The newest of the flocculation tests is the t~mol turbidity reported by 
Maclagen in 1944 (74). Again positive results depend upon the presence of increased 
gamma globulins. The test indicates acute liver damage and does not measure the de-
gree of this involvement (75). 
In several of our cases the thymol was active atter the cephalin cholesterol 
flocculation had subsided indicating that two different activity processes were pro-
bably responsible for the positive results. Franklin and his group (76) contend 
that the thymol turbidity test is closely related to liver cell regeneration but 
our results do not confirm this idea. 
-2-- Prothombin: 
This protein is found in the globulin fraction ot plasma and can be syntheSized 
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should result in a "decrease in the prothombin level of the blood. Our results 
do not show thiS. However, the test controls are inadequate requiring a standard 
to be run each time on "normal" blood. We recommend that Quick's test be replaced 
with the test which determines prothombin time and response to vitamin K therapy. 
The latter test is more sensitive and reliable in our opinion. 
D - Lipid Metabolism: -
The development of more accurate methods tor the determination ot cholesterol 
have increased investigation in the rela~ion of the liver to Cholesterol metabolism. 
There is still a great deal ot controversy on the subject but experimental evidence 
(65) points to the important role played by the liver in the intermediary meta-
bolism of lipoids. This organ appears to possess the power of removing cholesterol 
from the blood, storing it, and probably synthesizing the canpound. The liver is 
considered to be an active regulator of blood cholesterol and cholesterol esters. 
Several factors (68) influence the blood cholesterol level: 
1 - diurnal variation; 
2 - diet; 
3 - age. 
Greene and hi s sroup (66) have prepared the following chart illustrating our 
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Many investigators (66, 67) have found that in the presence of hepatic injury 
the cholesterol esters of the blood are reduce4 in amount or entirely absent. 
This seems to be true in acute diseases but not in the chronic processes - Cirrhosis. 
In our results only two cases out of sixteen show a slightl~ lowered blood choles-
terol ester level. Epstein (69) has reported a hyper cholesterolemia, both total 
and ester, observed in regeneration and healing of the diseased liver. Case 6 in 
our series may be an example of this healing effect. 
The enzyme lipase was also investigated. In 25% of our cases a rise 
was exhibited indicating pancreatic involvement associated with hepatic damage. 
-!-- Excretory function tested with brom8ulphalein dye: 
In 1924 Rosenthal (54) studied the physiological behavior of various halogenated 
phthalein dyes. These dyes when injected intravenously were removed by the liver 
and excreted in the bile. Continued research led Rosenthal and White (55) to the 
conclusion that the sulfonated phenoltetrahalogen phthalein group of dyes was the 
most satisfactory and of this group bromsulphalein possessed the best test re-
quirements. Positive results obtained with this test indicate impaired liver 
function. However, Rosenthal warns that, while test results may be interpreted 
quantitatively from a function standpoint, the relation between function and ex-
tent of patholOgical leSion may be widely divergent depending on the type of lesion 
and its duration. This is particularly true in chronic liver disease where re-
generation of cells may partially restore hepatic function, although diffuse scar 
tissue may be present. Our results illustrate this effect; only 12.5% of our cases 
demonstrated moderately severe hepatic damage by the bromsulphalein test. However, 
our other laboratory. results indicate a much larger percentage would be expected to 
show decreased excretion of the dye. 
Soffer (56) explains that the dye is excreted specifically by the liver, 
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although perhaps not quanti*atively as there is same evidence that the reticulo-
endothelial system is capable of taking up the dye. The test is relatively easy 
to perform and presents interesting evidence of liver regeneration in our group-
N. B. cases 2 and 3. However Rosenthal's method has been criticized because of 
its lack of sensitivIty (57). Macdonald (58) recommends a serial bromsulphalein 
test and graphically depicts the limitations of the thirty minute test based upon 
experimental evidence: 
% retention 100 
50 
o 20 30 
Time in minutes 
Normal liver function 
~- Secretory function of the liver: 
% retention 100 
50 
o 10 20 30 
Time in minutes 
Poor liver risk, althoug 
results within normal 
range 
The Kupfer cells of the liver are generally conceded to be the site of formation 
of bilirubin from hemoglobin. The 11 Ter epithelial cells function to excrete int.o 
the bile canaliculae the bilirubin carried by the blood stream. All of these mech-
anisms seem to escape severe damage in cirrhosis. Although the serum bilirubin 
shows slight elevation from time to time, a marked increase has not been observed 
in this series of cases. 
~- Detoxification mechanism of the liver: 
In numerous publications (59. 60) Quick has published reports dealing with the 
conjugation of benzoic acid and glycine to form hippuric acid. In 1938 Quick (61) 
reported an intravenous modification which seemed to be more sensitive in detecting 




acid measures the max1_ capacity ot the nor.aal l1ver to synthesize this sub-
stance; the second hour excretion contained much smaller amounts ot hippUTtc 
acid. However in the diseased 11 var the merse is true. 
This test measures a metabolic as well as detoxitication process oc-
curring in the liverp the rate otlh):ppufu acid tormation is dependent primarily 
on the rate ot glycine synthesis by the liver. White and his co-workers (62) have 
stated that the mechanism ot l!tppur1.c acid syntheSiS seems to have 11 ttle reserve 
and is easily upset. We have tound this. to be true and our results were similar 
to those reported by Hottbauer et al (63) in a study ot cirrhosis. 
While the test has been sensitive and reliable in the hands ot others 
(0.), many tactors intluence the results. Complete cooperation on the part ot 
the patient is re,uired. Also conditions ot dehydration (otten seen in cirrhosis) 
and kidney involvement may retard the elimination at syntheSized hippuric acid and 
result in low output. 
~- Nonprotein nitrogen: 
During the course ot the disease the non protein nitrogen shows slightly increased 
values in our reports. A signiticant increase 1s noted in the terminal stages ot 
the disease denoting decreased renal tunction. 
~- Carbohydrate metabolism: . 
EXperimental evidence indicates that galactose is metabolized specitically by 
the liver and that the conversion ot galactose to glycogen is not dependent upon 
the action ot insulin (77, 78, 79, 80, 81). Theretore galactose is the sugar ot 
choice tor testing the glycogenic function ot the liver. 
Since the liver slowly converts small amounts ot the sugar to glycogen, 
decreased tolerance to this substance is observed in the presence ot hepatic damage. 
In agreement with the results ot Bassett and Althausen (81), our data illustrates 
decreased galactose tolerance in the majo~ity ot our cirrhosis patients. Matked 
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hyperclycemia. indicating a decreased g$lactose tolerance, correlates with the 
impaired glycogenic tunction, found upon chemical determination of glycogen in 
biopsied liver specimens in our series of cases. The galactose tolerance test 
appears to be a sensitive indicator of the glycogenic capacity of the liver. 
Blood glucose was determined in order to observe any correlation be-
tween blood sugar level and liver glycogen. It is interesting to note that in-
creased blood glucose values paralleled decreased glycogen biopsy results. This 
might indicate that the liver is still c~pable of synthesizing and mobilizing 
glycogen but unable to store it (82). It would be interesting to determine whether 
blood lactate increases in conjunction with the increase in glucose level and de-
crease in liver glycogen. 
Determination of saylese provided no additional information concerning 
the functional state of the diseased liver. 
Glycogen is generally considered to be the reserve palysaccharide of 
the animal world, although its presence has been demonstrated in certain bacteria 
and fungi. Determination of liver glycogen by chemical analyses of biopsied tis-
sue otfers valuable information concerning the effect of disease upon the liver 
and particularly upon the storage ot this carbohydrate in the 11 ver. 
Claude Bernard first reported the existence ot glycogen in 1856 and 
developed a method tor its quantitative determination (83). Subsequent modifica-
tion and improvement of the method by Pfluger and others has resulted in the pre-
sent accurate and relatively simple micro-procedure. 
The molecular structure ot glycogen has been subjected to intensive in-
vestigation (84, 85, 86, 87. 88. 89, 90, 91. 92, 93). In the glycogen molecule 
the glucose residues are linked in chains by the ~ 1-4 glycosidic bond and the 
more stable 0\ 1-6 glycosidic bond. These chains appeared to be arranged in a 
highly branched structure as indicated by~'the red-brown color that the poly-
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saccharide gives with iodine. Experimental evidence shows that iodine color re-
actions w1 th polysaccaari(\eS . are dependent upon the degree ot branching and 
chain length ot the polysaccharide. A blue color represents a relatively un-
branched chain and a red color corresponds to a highly branched molecule. 
Meyer has proposed the multiple branching theory to depict the rami-
tied structure ot glycogen. His theory is based upon analysis ot the molecule 
Structure .2!. glycogen according ~ Meyer 
by methylation and enzymatic degradation. Employing the Haworth and Hdrst and 
group assay method. methylated glycogen has been tound to contain one terminal 
glucose unit per eleven glucose residues. Glycogen is then subjected to attack 
by B-amylase and 47% ot the molecule is degraded. The residual deatrin is again 
assayed and tound to contain 18% terminal groups - ie, one terminal group per 5.5 
glucose units. This data provides evidence tor the compact structure ot the re-
sidual dextrin with its multiple branching. The intact glycogen molecule contains 
exterior branches ot 6-7 glucose units. 
Since interior and exterior branches in the molecule are short, glycogen 
lends i tselt to a more compact structure which is spherical in shape as has been 
veritied experimentally with the van't Hott laws ot osmotic pressure. The size 
ot the native molecule is indicated by its large molecular weight which is in ex-
cess ot tour million. 
Glycogens ingested in the diet are probably broken down completely into 
glucose by the ~lase8 and glucosidases ot the digestive tract. Glycogens are 
also degraded by ~ 1-4 and 0(. 1-6 phosphorylases. In the presence ot inorganic 
phosphate and glycogen, the phosphory1as8"enzymes catalyze the reaction by which 
• 
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orthophosphoric acid cleaves the glycosidic linkages and yields glucose-l-Phosphate. 
An intramolecular phosphate transfer to glucose-6-phosphate is then aided by the 
enzyme phosphoglucomutase. 
Phosphorolysis is reversible the direction of the reaction being deter-
mined by the relative concentrations of glucose-I-phosphate and inorganic phosphate. 
The removal of inorganic phosphate favors glyco~nesis while its addition hastens 
glycogenolysis. In the intact animal the removal of phosphate is accomplished by 
the oxidation of carbohydrate which is c?upled with the regeneration of ATP and so 
permits the phosphate donor to be used over again in the hexokinase reaction. 
The synthesis and breakdown of glycogen is affected by many factors 
(94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105. 106, 107, 108, 109, 110). 
Only a few of these factors will be considered in this paper. 
Cori has demonstrated, in vitro, that the synthesis of a polysaccharide 
from monosaccharides requires the presence of a small amount of the polysaccharide 
and that the process involves a building up of chains and branches. 
glucose-I-phosphate + terminal glucose unit (of glycogen) phoBphate .. 
~ 1-4 glycosidic chain unit of 
polysaccharide 
In addition to reaction kinetics, the hormonal balance of the body in-
fluences glycogenesis and glycogenolysis. Stetten has determined that adrenalin 
stimulated anaerobic glycolysis in the muscle with subsequent liberation of lactic 
acid which is utilized for glycogenesis in the liver. He further determined that 
the deposition of glycogen in the muscle is favored by insulin. The reason for 
this reaction can be explained on the basis of Corl's work. Cori showed that the 
first step in tissue utilization of glucose -
ie, glucose ~ ATP hexokinase glucose-6-phosphate + ADP 
~ 
is inhibited by the action of an anterior pituitary extract upon the hexokinase 
reaction and that this inhibition is opposed by insulin. 
- 17 -
The close integration ot carbohydrate metabolism with fat and protein 
metabolism has been verified with isotopic studies. A simplified presentation ot 


















fragment + phosphate ~oxidation 
JI' 
amino acids 
We feel that continued chemical studies of liver glycogen will contribute 
much valuable information eoneerning the function of the normal and pathological 
liver. Due to the various inter-relationships involved in the synthesis and stor-
age of glycogen, we believe that greater insight into body metabolism in diseased 
states oan be obtained. However, glycogen determinations alone oan not validate any 
hepatic diagnoses but they must be considered in relation to other tests of liver 
functiOll. Investigation of metabolic diseases in a manner similar to the proced-
ures outlined in this paper offers untold opportunities to further the knowledge 
of abnormal body metabolism. 
Within the limits imposed by the study of a small number of cases, we 
believe that liver glycogen assay affords a sensitive indication of eXisting hepatic 
pathology. However we were unable to obtain any biopsies Just prior to death and 
therefore could not investigate this hepatic pathology and compare it with post 
mortem findings. Continued efforts in this field will probably furnish further in-
sight into general body metabolism and additional data in order to secure better 
clinioal diagnosis. 











Cephalin cholesterol flocculation 2+ 
Colloidal gold 55443211' 
Thymol turbidity 5.2 units 
Prothrombin 
Total cholesterol 316.8 mg% 
Free cholesterol 81.6 mg% 









Bromsulphalein dye - retention 30 min. 72.5% 
" 60 min. 3 % 
Bilirubin 
3.5 units 
Hippuric acid 0.07 gm sodium benzoate 
Nonprotein nitrogen 37.6 mg% 214.8 mg% 
Amylase --. 






First biopsy (1-9-48) specimen showed considerable increase in fibrous con-
nective tissue; remaining liver cells quite granular and swollen. 
Diagnosis: cirrhosis, portal 
Second biopsy (3-15-48) no pathological specimen 
Death oocurred 4-16-48 (hemorrhage) 































0.5 ec sodium hydroxide 
Bromsulphalein dye - retention 30 min. 14.5% Retention 30 min. 2.5% 
Bilirubin 
Hippuric acid 





" 60 min. 5.5% " 60 min. negative 
60 min. 
75 min. 
0.16 gm sodium benzoate 0.05 gill sodium .enzoate 
41.9 mg% 44.9 mg% 
94.3 mg% 80.2 mg% 








PaJllological Reports: first biopsy (1-13-48) report was cirrhosis with 
acute degeneration. Appearance of some of the cells 
suggested Regeneration. 
Second biopsy (2-9-48) was unsuccessful. HOW9yer 
ascitio fluid was examined and no canoer cells were found. 
Note the improvement of the liver functions dye excretion and carbohydrate 
metabolism in the chemical tests (2-9-48) which would suggest some oellular re-
generation as reported by the pathologist (1-13-48). 
Oase 3 - =r .B. (m.w.) Age 52 
Ohemical reports 1-13-48 
Total protein 7.3 sm% 
Albumin 2.1 gm% 
Globulin 5.2 sm% 
A/G ratio 0.4 

















Lipase 0.5 cc sodium hydroxide 
Bromsulphalein dye - 30 min. retention 28% 30 min. retention 5% 
60 min. retention 17.8% 60 min. retention 3% 
Bilirubin 0.9 ms% 
Hippuric acid 011 gm sodium benzoate 0.06 gm.sodium benzoate 

















Pathological reports: First biopsy (1-13-48) showed acute degeneration of the 
liver. Slight amount of fibrous connective tissue pre-
sent; liver cells were very granular in appearance. 
Second biopsy (2-9-48) report was increased fibrosis. 
Diagnosis: moderate cirrhosis of the liver. 
An increase in liver damage can be seen in second series of chemical tests 
and is in accord with the interpretation of the patholOgist. Death occurred 
3-15-48. 
























Bromsulphalein dye - 30 min. retention 47% 
60 min. retention 33.8% 
Bilirubin 0.6 ~ 
Hippuric acid 0.08 gm. sodium benzoate 









5.9 % (approx.) 
Pathological reports: First biopsy specimen (1-20-46) contained large amounts of 
fibrous connective tissue. Cytoplasm was granular and ap-
peared to be undergoing degenerative change. 
Interpretation: cirrho*is; tatty liver. 
Both cheBdcal and pathological reports indicate activity. Although the cephalin 
cholesterol tlocculation test is negative, the thymol turbidity test indicates an 
active process in the diseased liver. Hippuric acid synthesis and albuminT!1obulin 
ratio results show hepatic d;atunction. . 
Case 5 - D.G. (m.w.) Age 7 
Chemical Reports: 1-28-48 
Total protein 6.8 gm% 
Albumin 2.9 gm% 
Globulin 3.9 f!Jl1% 
A/G ratio 0.7 
Cephalin Cholesterol negative 
Colloidal Gold '54321 
Thymol Turbidity 2.8 units 
Prothrombin --
Total Cholesterol 128.5 mg% 
Free Cholesterol 66.7 mg% 
Chole8~.rol esters 48% 
Lipase ---
Bromsulphalein dye - 30 min. retention None 
Bilirubin 0.5 mg% 
Hippuric Acid 0.095 gm sodium benzoa~e 
(recovered after injection of 0.44 gm) 
Nonprotein Nitrogen 35.3 mg% 
Amylase 48.6 mg% 
Glucose 89.4 mg% 
Galactose Tolerance - 60 minutes 34.1 mg% 
75 minutes 26.5 .mg% 
Glycogen first specimen 5.9% 
Second spec1men 4.7% 
Pathological Reports: First biopsy speclmen (1-28-48) contained excessive 
amounts of fibrous connective tissue. Loss of normal cell 
architecture with swelling and granularity was reported. 
Interpretation: cirrhosis (early, portal); acute degenera-
tion (severe) 
Clinical diagnosis: Detonl-Fancon1 syndrome 
Note degree of involvement suggested by albumin-globulin ratio and colloidal 
gold tests. The functions of dye excretion and hlppuric acid synthesis appear 
normal. 
























0.4 cc sodium hydroxide 
Bromsulphalein dye - 30 min. retention 4.0% 
60 min. retention None 





Galactose Tolerance - 60 minutes 
75 minutes 
Glycogen 






Patholo!1cal Reports: No specimen 
The results of the function tests indicate a cirrhotic condition with no active 
lesion at the time of testing. The biopsied glycosen assay end hippuric acid 
synthesis are very low. Normal results obtained in the bromsulphalein test might 
indicate some regeneration. Negative cephalin cholesterol flocculation and thymol 
turbidity tests indicate no active leSion at the time of testing. 














Bromsulphalein dye - 30 min. retention 










8.5 f!Jf1% 6.9 gm% 
2.4 gm~ 2.1 gm.% 
6.1 gm.% 4.8 gm% 
0.4 0.4 
~ ... 2 ... 
543211 ---
4.5 units 3.9 units 
89% 91.2% 
123.5 mg% 
33.2 mg% 38.2 mg% 
--- 69% 
1.0 cc sodium hydroxide 
27.5% 
15% 
30 min. retention - 23% 
60 min. retention - 9%" 
1.3 mg% 
0.04 gill sodium benzoate 0.02 gm sodium benzoate 
71.9 mg% 
125.9 mg% 
107.3 mg% 60 min. -






Pathological reports: First biopsy specimen (2-24-46) showed peri lobular fibrosis. 
Individual liver cells showed granular cytoplasm and in some 
areas cell borders were indistinct. Cytoplasm contained 
large fat va~oles in moderate amount. 
Second biopsy (3-15-46) showed all liver cells with a marked 
degree of swelling and granularity. There was slight dit-
tuse fat infiltration. A moderate amount of fibrous con-
nective tissue was reported. 
Interpretation: ~irrhosis, portal; fatty liver. 





































0.8 cc sodium hydroxide 
30 min. retention - 21% 









Fatho1ogica1 Reports: No biopsy obtained. 
Note function impairment ot hippuric acid synthesis, carbohydrate metabolism and 
dye excretion. As the cephalin cholesterol flocculation activity decreases the 
thymol turbidity activity increases. The albumin is dangeroui1y low. -Death 
occurred 3-15-48. 
Case 9, C.B. (m.w.) Age 64 





Cephalin Cholesterol 3 .& 
Colloidal Gold 






Bromsulphalein dye - 30 min. retention 











3 " 3 .& 2 " 
553211 







2.9 cc sodium hydroxide ---
30 min. retention - 22.5% 
60 min.retention - 8.5% 
0.7 mg% 
0.1 gm sodium benzoate 0.04 gm.sodium benzoate 
4011 mg% 61.7 mg% 
181.3 mg% 116.2 mg% 
146.1 mg% 
60 min. - 135.4 mg% 
75 min. - 93 mg% 
2.5% 
Pathological Reports: Birst biopsy (2-26-48) section showed liver cells with 
considerable granulation and irregularity in size. Large 
groups of liver cells, believed to be lobules, were sur-
rounded by a considerable amount of fibrous connective tis-
sue. 
Second biopsy (3-15-48) contained liver cells which showed 
large amount of cloudy swelling and considerable loss of 
detail. 
Interpretation: cirrhosis, severe; aette degeneration 
Note correlation between pathologieal and chemical reports. Second series of 
funetion tests indicate slight improvement of hepatie tunction. 
Case 10, R.G. (m.w.) Age 44 
Chemical Reports: 2-26-48 
Total protein 6.8 gm~ 
Albumin 
Globulin 
A./G Ratio 0.6 
Cephalin Cholesterol 2 ... 
Colloidal Gold 32211 
Thymol Turbidity 3.5 units 
Prothrombin 
Total Cholesterol 245.2 mg% 
Free Cholesterol 51.1 mg% 
Cholesterol esters 79% 
Lipase 6.2 cc sodium hydroxide 
Bromsulphe.lein dye - 30 min. retention 10% 






Galactose Tolerance - 60 minutes 
75 minutes 
Glycogen 








Pathological Reports: First biopsy (2-26-48) section showed a considerable 
amount of granularity and irregularity in size of liver 
cells. Nuclei were quite large suggesting regeneration. 
Densely scattered fat cells apparently caused considerable 
atrophy of the liver. 
Interpretation: fatty liver. 
Clinical diagnOSis: cirrhosis. 
Chemical reports indicate severe involvement of the liver with decreased function 
in protein and carbohydrate metabolism and hippuric acid synthesis. The floccula-
tion tests (3-9-48) indicate increased activity of the hepatiC lesion. 
Case 11, G.B. (m.w.) 
Chemical reports: 4-21-48 
Total protein 7.6 gm% 
Albumin 3.9 gm% 
Globulin 3.7 gIIl% 
A/G ratio l.it 
Cephalin Cholesterol 1 .l 
Colloidal Gold 





Lipase 0.6 co sodium hydroxide 
Bromsulphalein dye - 30 min. retention 20% 
60 min. retention 10% 
Bilirubin 1.5 mg% 
Hippuric Acid 0.05 gin sodium benzoate 
Nonprotein Nitrogen 68.4 mg% 
Amylase 81.3 mg% 
Glucose 78.1 m~ 






Summary and Conclusions 
1. The 1l7c08~ assay in conjunction with the albumin-globulin ratio and galactose 
tolerenee were tound to be the most sensitive chemical tests indicative ot liver 
pathology in this series of cases. 
2. Pathological reports ot cellular abnormality corresponded in a large number ot 
cases with low glycog$n values obtained tram biopsies. 
3. The colloidal @Old test was positive in all cases. 
4. Cephalin cholesterol flocculation an~ thymol turbidity tests showed episodes 
of spasmodic activity throughout the course ot the disease. 
5. Hippuric acid synthesis seemed to indIcate a great loss ot heaptic function 
in many ot the patients but this did not correlate with the amount ot damage 
as shown by the bromsu)phalein test. 
6. Total protein, amylase, prothrombin end bilirubin remained within normal range. 
Non protein nitrog$n increased in the terminal stages ot the disease probably 
due to loss ot renal function. 
7. Determination ot glycogen in biopsied liver specimens provided a useful method 
tor the continued study of the diseased organ durante vivo. 
The author wishes to express her thanks to Dr. R. J. Vanloon, Dr. A. J. Miller 
end Dr. Herbert Clay for their guidance and cooperation throughout the project. 
The author also wishes to express her gratitude to Dr. A. W. Homberger. whose 
sanction made this project possible. 
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